Iwanaga Kazunori, Honjo Tatsuya, Miyazaki Makoto, Kakemi Masawo
Division of Pharmaceutics, Osaka University of Pharmaceutical Sciences, Nasahara, Takatsuki, Osaka, Japan.
Xenobiotica. 2013 Sep;43(9):765-73. doi: 10.3109/00498254.2012.761741. Epub 2013 Jan 23.
We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively. The number of times DEX-P was administered was not a significant factor in the induction of either hepatic or intestinal CYP3A; however, administration of DEX-P multiple times markedly decreased the bioavailability of DEX-P by self-induction of CYP3A. CYP3A induction in the liver increased depending on the dose of DEX-P, whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of DEX-P. Administration of a single dose of DEX-P showed a temporal increase in CYP3A activity in both tissues and the induction ratios reached maximum values at 12 h after DEX-P administration. On the other hand, a mild increase of CYP3A activity, which lasted for at least 48 h, was observed in both tissues after administration of multiple doses. Some physiological compounds such as cytokines might be involved in decreasing the CYP3A activity to maintain homeostasis of the body.
我们分别使用21 - 磷酸地塞米松(DEX - P)作为诱导剂、咪达唑仑(MDZ)作为细胞色素P450 3A(CYP3A)的底物,研究了诱导剂给药剂量、给药次数以及诱导持续时间对大鼠肝脏和肠道中CYP3A的影响。DEX - P的给药次数并非肝脏或肠道CYP3A诱导的显著因素;然而,多次给予DEX - P会通过CYP3A的自身诱导显著降低DEX - P的生物利用度。肝脏中CYP3A的诱导随DEX - P剂量增加而增加,而肠道中的诱导仅轻度增加,且无论DEX - P剂量如何,诱导水平几乎恒定。单次给予DEX - P后,两个组织中的CYP3A活性均出现短暂增加,诱导率在给予DEX - P后12小时达到最大值。另一方面,多次给药后,两个组织中均观察到CYP3A活性轻度增加,且至少持续48小时。一些生理化合物如细胞因子可能参与降低CYP3A活性以维持机体的稳态。